| TRVPX | VEVYX | TRVPX / VEVYX | |
| Total Expense Ratio | 0.61 | 0.66 | 92% |
| Annual Report Gross Expense Ratio | 0.61 | 0.66 | 92% |
| Fund Existence | 17 years | 13 years | - |
| Gain YTD | 15.017 | 9.989 | 150% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.67B | 15.2B | 11% |
| Annual Yield % from dividends | 1.40 | 1.20 | 117% |
| Returns for 1 year | 21.35 | 11.82 | 181% |
| Returns for 3 years | 46.87 | 15.22 | 308% |
| Returns for 5 years | 5.44 | 2.62 | 207% |
| Returns for 10 years | 4.53 | 66.13 | 7% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AGGDX | 12.83 | N/A | N/A |
| American Century Focused Global Gr R6 | |||
| TPISX | 15.76 | N/A | N/A |
| Nuveen Quant Intl Small Cap Eq Premier | |||
| CWSGX | 24.16 | N/A | N/A |
| Carillon Chartwell Small Cap Growth I | |||
| FXAIX | 264.46 | N/A | N/A |
| Fidelity 500 Index | |||
| JAGLX | 77.51 | -2.09 | -2.63% |
| Janus Henderson Global Life Sciences T | |||